[Simplified HIV therapy. Atazanavir: the first protease inhibitor with once daily administration].
D000328:Adult; D000069446:Atazanavir Sulfate; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D061466:Lopinavir; D009842:Oligopeptides / Q000008:administration & dosage* / Q000009:adverse effects; D011725:Pyridines / Q000008:administration & dosage* / Q000009:adverse effects; D011744:Pyrimidinones / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome
D003692:Delayed-Action Preparations; D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011725:Pyridines; D011744:Pyrimidinones; D061466:Lopinavir; D000069446:Atazanavir Sulfate
Vereinfachung der HIV-Therapie. Atazanavir: der erste Proteasehemmer für die einmal tägliche Einnahme.